Immunohistochemical determination of the P15INK4b protein expression in cutaneous squamous cell carcinoma

Journal of Cutaneous Pathology

Volumn 36, Issue 2, 2009, Pages 183-189

  Moad, Ahmed I ^a   Lan, Tan Mei ^a   Kaur, Gurjeet ^a   Hashim, Hasnah ^a   Mabruk, Mohamed J E M F ^b  

^a ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

^b UNIVERSITI BRUNEI DARUSSALAM   (Brunei Darussalam)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

CYCLIN-DEPENDENT KINASE INHIBITOR P15; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, SQUAMOUS CELL; SKIN NEOPLASMS;

EID: 58649093761     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.00989.x     Document Type: Article

References (41)

1. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992 26 : 467.
2. Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992 26 : 1.
3. Weinstock MA. Death from skin cancer among the elderly: epidemiological patterns. Arch Dermatol 1997 133 : 1207.
4. Weinstock M, Bogaars H, Ashley M, et al. Nonmelanoma skin cancer mortality. A population-based study. Arch Dermatol 1991 127 : 1194.
5. American Cancer Society. Cancer facts and figures 2007. Atlanta, GA : American Cancer Society, 2007.
6. Andrew LO, Steven MM, Regina MP, Stuart DS. Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy. J Am Acad Dermatol 2006 55 : 1092.
7. Ziegler A, Leffell, DJ, Kunala S, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 1993 90 : 4216.
8. Dalziel, KL. Aspects of cutaneous ageing. Clin Exp Dermatol 1991 16 : 315.
9. Koh HK, Kligler BE, Lew RA. Sunlight and cutaneous malignant melanoma: evidence for and against causation. J Photochem Photobiol 1990 51 : 765.
10. Marks R, Rennie G. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1998 1 : 795.
11. Hannon GJ, Beach D. p15 INK4B is potential effectors of TGF-beta-induced cell cycle arrest. Nature 1994 371 : 257.
12. Morgan DO. Principles of CDK regulation. Nature 1995 374 : 131.
13. Nurse P. Ordering S phase and M phase in the cell cycle. Cell 1994 79 : 547.
14. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994 79 : 551.
15. Lee MH, Reynisdottir I, Massague J. Cloning of p57KIP2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995 9 : 639.
16. Matsuoka S, Edwards MC, Bai C, et al. p57KIP2, a structurally distinct member of the p21CIP 1 CDK inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995 9 : 650.
17. Guan K-L, Jenkins CW, Li Y, et al. Growth suppression by p18, p16 (INK4/MTS1) and p14 (INK4B/MTS2)-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 1994 8 : 2939.
18. Hunter T, Pines J. Cyclins and cancer: II. Cyclin D and CDK inhibitors come of age. Cell 1994 79 : 573.
19. Sefik G, Iin P. Cumulation of TP53 Mutations and p16 INK4A/p15 INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer. Cancer Genet Cytogenet 1999 109 : 108.
20. Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001 2 : 731.
21. Tanaka H, Shimada Y, Imamura M, Shibagaki I, Ishizaki K. Multiple types of aberrations in the p16 (INK4a) and the p15 (INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines. Int J Cancer 1997 70 : 437.
22. Reynisdottir I, Polyak K, Iavarone A, Massagué J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 1995 9 : 1831.
23. Alejandro M, Alicia S, Yanelys M, Silvio E. P27Kip1: regulation and function of a cell cycle key regulator. Biotecnol Apl 2001 18 : 193.
24. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin/CDK4. Nature 1993 366 : 704.
25. Nakashima R, Fujita M, Enomoto T, et al. Alteration of p16 and p15 genes in human uterine tumours. Br J Cancer 1999 80 : 458.
26. Koduru PR, Zariwala M, Soni M, et al. 1995). Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. Blood 1995 86 : 2900.
27. Shintani S, Nakahara Y, Mihara M, Ueyama, Y, Matsumura T. Inactivation of the p14 (ARF), p15 (INK4B) and p16 (INK4A) genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol 2001 37 : 498.
28. Kawamata N, Miller CW, Koeffler HP. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers. Mol Carcinog 1995 14 : 263.
29. Nakamaki T, Kawamata N, Schwaller J, et al. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. Br J Haematol 1995 91 : 139.
30. Roesler JM, Livingston EH, Srivatsan E, Chang P, Wang MB. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas. J Surg Res 1998 77 : 50.
31. Ichikawa Y, Yoshida S, Koyama Y, et al. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors. Int J Cancer 1996 69 : 466.
32. Stadler WM, Olopade OI. The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes. Urol Res 1996 24 : 239.
33. Sarah EG, Elaine K, Mary L, Mabruk M. Analysis of p16 expression and allelic imbalance/loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas. J Cell Mol Med 2006 10 : 778.
34. El-Shakankiry NH, Mossallam GI. p15 (INK4B) and E-cadherin CpG island methylation is frequent in Egyptian acute myeloid leukemia. J Egypt Natl Canc Inst 2006 18 : 227.
35. Papageorgiou SG, Lambropoulos S, Pappa V, et al. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia. Am J Hematol 2007 82 : 824.
36. Sonodo Y, Yoshimoto T, Sekiya T. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Oncogene 1995 11 : 2145.
37. Saridaki Z, Liloglou T, Zafiropoulos A, et al. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of skin. Br J Dermatol 2003 148 : 638.
38. Mortier L, Marchetti P, Delaporte E, et al. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16 (INK4a) tumor suppressor. Cancer Lett 2002 176 : 205.
39. Quinn AG, Campbell C, Hearly E, Rees JL. Chromosome 9 allele loss occurs in both basal and sequamous cell carcinoma of the skin. J Invest Dermatol 1994 102 : 300.
40. WAF1/CIP1 in human breast cancer. Int J Cancer 1995 63 : 584.
41. Liu XQ, Zeng RS, Huang HZ, Liao GO. Expression of p15 and p16 proteins in tongue squamous cell carcinoma and their significances. Ai Zheng 2003 22 : 1214.